Pre-treatment lymphocyte count predicts cisplatin benefit with radiotherapy in oropharynx cancer

There is a need to refine the selection of patients with oropharynx squamous…" />

We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.